Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group

on behalf of ELIOS

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group'. Together they form a unique fingerprint.

Medicine & Life Sciences